Literature DB >> 1846036

Malignant melanoma in transgenic mice.

M Bradl1, A Klein-Szanto, S Porter, B Mintz.   

Abstract

Ocular and cutaneous melanomas arose in new inbred lines of transgenic mice having an integrated recombinant gene comprised of the tyrosinase promoter, expressed in pigment cells, and the simian virus 40 early-region transforming sequences. The tumors were hypomelanotic and were histopathologically similar to corresponding human melanomas. Eye melanomas often originated at a young age, chiefly from the retinal pigment epithelium, also from the choroid, and rarely from the ciliary body. The eye tumors grew aggressively, were highly invasive, and metastasized to local and distant sites. The earliest formation of these tumors was associated with higher copy numbers of the transgene; mice of different single-copy lines varied greatly in age of onset and frequency of eye tumors. Coat pigmentation was reduced in almost all lines, to various extents. Primary skin melanomas arose later and less frequently than eye melanomas. Hence they were at early stages and of unknown long-range incidence in this investigation, in which autopsies covered the first half-year of life. For both ocular and cutaneous melanomas, the transgenic mice offer numerous possibilities for experimental study of mechanisms underlying formation and spread of melanomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846036      PMCID: PMC50770          DOI: 10.1073/pnas.88.1.164

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice.

Authors:  D M Ornitz; R E Hammer; A Messing; R D Palmiter; R L Brinster
Journal:  Science       Date:  1987-10-09       Impact factor: 47.728

2.  Melanoma cell heterogeneity. A study of two monoclonal antibodies compared with S-100 protein in paraffin sections.

Authors:  P H Duray; J Palazzo; A M Gown; N Ohuchi
Journal:  Cancer       Date:  1988-06-15       Impact factor: 6.860

3.  Complete nucleotide sequence of SV40 DNA.

Authors:  W Fiers; R Contreras; G Haegemann; R Rogiers; A Van de Voorde; H Van Heuverswyn; J Van Herreweghe; G Volckaert; M Ysebaert
Journal:  Nature       Date:  1978-05-11       Impact factor: 49.962

4.  The rate of malignant melanoma in the United States: are we making an impact?

Authors:  D S Rigel; A W Kopf; R J Friedman
Journal:  J Am Acad Dermatol       Date:  1987-12       Impact factor: 11.527

5.  Experimental malignant tumors from retinal pigment epithelium.

Authors:  D M Albert; M O Tso; A S Rabson
Journal:  Arch Ophthalmol       Date:  1972-07

Review 6.  Teratocarcinomas and other neoplasms as developmental defects in gene expression.

Authors:  B Mintz; R A Fleischman
Journal:  Adv Cancer Res       Date:  1981       Impact factor: 6.242

7.  Melanosis and associated tumors in transgenic mice.

Authors:  A Klein-Szanto; M Bradl; S Porter; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

Review 8.  On the histological diagnosis and prognosis of malignant melanoma.

Authors:  A Levene
Journal:  J Clin Pathol       Date:  1980-02       Impact factor: 3.411

9.  The human beta-globin gene and a functional viral thymidine kinase gene in developing mice.

Authors:  E F Wagner; T A Stewart; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

10.  Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment.

Authors:  G P Dotto; G Moellmann; S Ghosh; M Edwards; R Halaban
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

View more
  43 in total

1.  Up-regulation of specific tyrosinase mRNAs in mouse melanomas with the c2j gene substituted for the wild-type tyrosinase allele: utilization in design of syngeneic immunotherapy models.

Authors:  N Le Fur; W K Silvers; S R Kelsall; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

2.  UVB induces atypical melanocytic lesions and melanoma in human skin.

Authors:  E S Atillasoy; J T Seykora; P W Soballe; R Elenitsas; M Nesbit; D E Elder; K T Montone; E Sauter; M Herlyn
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

3.  Malignant tumor of the retinal pigment epithelium with extraocular extension in a phthisical eye.

Authors:  K U Loeffler; T Kivelä; H Borgmann; H Witschel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

4.  Changes in expression of putative antigens encoded by pigment genes in mouse melanomas at different stages of malignant progression.

Authors:  S J Orlow; V J Hearing; C Sakai; K Urabe; B K Zhou; W K Silvers; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

5.  Pigmented uveal tumours in a transgenic mouse model.

Authors:  T R Kramer; M B Powell; M M Wilson; J Salvatore; H E Grossniklaus
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

6.  Melanosis and associated tumors in transgenic mice.

Authors:  A Klein-Szanto; M Bradl; S Porter; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

Review 7.  Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development.

Authors:  Yarí E Marín; Suzie Chen
Journal:  J Mol Med (Berl)       Date:  2004-08-21       Impact factor: 4.599

8.  Molecular basis of dark-eyed albinism in the mouse.

Authors:  A Schmidt; F Beermann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

Review 9.  G-protein-coupled receptors and melanoma.

Authors:  Hwa Jin Lee; Brian Wall; Suzie Chen
Journal:  Pigment Cell Melanoma Res       Date:  2008-05-27       Impact factor: 4.693

10.  Uniform cell-autonomous tumorigenesis of the choroid plexus by papovavirus large T antigens.

Authors:  J D Chen; T Van Dyke
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.